VJHemOnc is committed to improving our service to you

EHA 2019 | Targeting multiple myeloma antigens

VJHemOnc is committed to improving our service to you

Rakesh Popat

Rakesh Popat, MBBS, MRCP, FRCPath, PhD, University College London Hospitals NHS Foundation Trust, London, UK, discusses target antigens in multiple myeloma, namely CD38 and BCMA, and the rationale behind their therapeutic targeting.This interview took place at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter